世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

体外診断薬市場レポート：2025-2035

体外診断薬市場レポート：2025-2035


In Vitro Diagnostics Market Report 2025-2035

概要 体外診断薬市場レポート 2025-2035年 （米国貿易関税の影響を含む）： 本レポートは、業界とその基礎となるダイナミクスをよりよく理解したい場合、新たな収益ポケットを目指している大手企業に... もっと見る

　

　

出版社 出版年月 電子版価格 納期 ページ数 言語
Visiongain
ヴィジョンゲイン社 		2025年6月9日 GBP5,150
部署ライセンス
ライセンス・価格情報
注文方法はこちら 		2営業日程度 356 英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

概要

体外診断薬市場レポート 2025-2035年（米国貿易関税の影響を含む）： 本レポートは、業界とその基礎となるダイナミクスをよりよく理解したい場合、新たな収益ポケットを目指している大手企業にとって貴重なものとなるでしょう。また、異業種への進出や新規地域での既存事業の拡大を目指す企業にとっても有用である。

技術の進歩が業界の成長を促進

体外診断薬（IVD）分野は、精度、携帯性、手頃な価格を向上させる診断技術の進歩に後押しされ、著しい成長を続けている。2025年5月、米国食品医薬品局（FDA）がアルツハイマー病の診断に役立つ初の血液検査を承認し、注目すべきマイルストーンが達成された。富士レビオ・ダイアグノスティックスが開発したルミパルスG pTau217/β;-Amyloid 1-42 Plasma Ratio検査は、アルツハイマー病に関連する特定のバイオマーカーを測定するもので、PETスキャンや脊髄穿刺のような従来の診断方法に代わる、より低侵襲で利用しやすい検査法である。今回の承認により、アルツハイマー病の早期発見と管理が改善され、特に高齢化社会に貢献することが期待される。

これと並行して、最小残存病変(MRD)を検出するための血液ベースの検査が採用され、がん診断の状況は一変しつつある。ガーダント・ヘルス社、ナテラ社、イグザクト・サイエンシズ社などの企業はこの革命の最前線にあり、循環腫瘍DNAを利用して従来の画像診断法よりもはるかに早期にがんの再発を特定している。これらの進歩は、よりタイムリーな介入と個別化された治療戦略を可能にし、がん医療に大きな変化をもたらしている。

セグメント分析

2025年現在、IVD市場では試薬分野が市場シェアの60％以上を占め、優位を維持している。この分野は、継続的な技術革新と新規診断試薬・キットの開発により、2035年まで最も高い年平均成長率（CAGR）を示すと予測されている。最近の例としては、自己免疫診断強化のためのWerfen社のAptiva試薬のFDA認可が挙げられる。これらの試薬は、自己免疫疾患の検出における特異性と効率を改善するもので、診断精度の向上に対する業界のコミットメントを反映している。

さらに、個別化医療の需要がコンパニオン診断薬の成長を促進している。2025年1月、Tempus AI, Inc.はFDA承認の次世代シーケンシング（NGS）ベースの体外診断薬xT CDxの国内発売を発表した。この包括的な検査は、広範な遺伝子変化に関する洞察を提供し、臨床医ががん患者の標的療法を選択する際に役立つ。このような先進的な診断法が臨床に導入されることは、精密医療を可能にする試薬の重要な役割を強調するものである。

IVD業界が進化を続ける中、革新的な試薬や診断ツールの研究開発への投資は引き続き極めて重要である。これらの分野に注力する企業は、最先端のソリューションで新たな医療ニーズに対応し、競争環境をリードする立場にある。

米国の貿易関税が体外診断薬の世界市場に与える影響とは？

米国の貿易関税が世界の体外診断薬（IVD）市場に与える影響は大きく、様々な地域のコスト構造やサプライチェーンダイナミクスに影響を及ぼす可能性がある。試薬、分析装置、コンポーネントを含む多数の体外診断薬（IVD）製品が、中国、ドイツ、日本などの国々から米国に輸入されている。これらの輸入品に対する関税は、米国を拠点とする診断薬企業の販売原価を上昇させ、利益率を押し下げたり、医療提供者や患者の価格を上昇させる可能性がある。

世界的な波及効果は、サプライチェーンの再編成にも及び、企業は調達先や製造拠点を関税免除国に移す可能性があり、その結果、業務の複雑さや経費が増大する。さらに、関税をめぐる不確実性は、特にグローバル・パートナーシップに依存する中小の体外診断用医薬品企業にとって、技術革新や国際共同研究への投資を先送りする可能性がある。EUやアジア太平洋地域などでは、国内生産を強化したり、非米国市場への輸出で競争上の優位性を確保したりする機会が生まれる可能性がある。長期的には、持続的な関税は現地化戦略を促進し、地域的な提携関係を培い、世界の体外診断用医薬品業界の競争力学を一変させる可能性がある。

市場調査レポートを購入する前にすべき質問とは？

  • 体外診断薬市場はどのように進化しているのか？
  • 何が体外診断薬市場を牽引し、阻害しているのか？
  • 体外診断薬サブマーケットの各セグメントは予測期間中にどのように成長し、2035年にはどれくらいの売上を占めるようになるのか？
  • 2025年から2035年にかけて、体外診断薬の各サブマーケットの市場シェアはどのように推移するか？
  • 2025年から2035年にかけて市場全体を牽引する主な要因は何か？
  • 体外診断薬の主要市場はマクロ経済ダイナミクスに概ね追随するのか、それとも個々の国市場が他を凌駕するのか。
  • 2035年までに各国市場のシェアはどのように変化し、2035年にはどの地域が市場をリードするのか？
  • 主要プレイヤーは誰で、予測期間中の見通しは？
  • これらの大手企業の体外診断薬プロジェクトとは？
  • 2025年から2035年にかけて、業界はどのように発展していくのか？
  • 現在進行中の
  • 体外診断薬プロジェクトは現在、そして今後10年間でどのような意味を持つのか？
  • 体外診断薬市場をさらに拡大するために、製品の商業化の必要性は高まっているか？
  • 体外診断薬市場はどこへ向かっているのか、そしてどのようにすれば市場の最前線に立つことができるのか？
  • 新製品やサービスラインに対する最適な投資オプションは何か？
  • 企業を新たな成長軌道に乗せ、C-suiteに導くための重要な展望とは？

このことが体外診断薬市場に現在、そして今後10年間にどのような影響を与えるかを見極める必要がある：

  • 2035年までの収益予測に加え、直近の実績、成長率、市場シェアを提供します。
  • ビジネスの展望と展開に関する独自の分析もご覧いただけます。
  • 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因など）、ポーターのファイブフォース分析、PEST分析、最近の動向をご覧いただけます。

2035年までの予測やその他の分析から、商業的な展望が見えてきた

  • 2035年までの収益予測に加え、最新の実績、成長率、市場シェアも提供する。
  • ビジネスの展望や展開など、独自の分析が掲載されている。
  • 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因など）、ポーターのファイブフォース分析、PEST分析、最近の動向をご覧いただけます。

レポート対象セグメント

製品

  •  機器 
  • 試薬・キット

テスト

  • 臨床化学
  • 免疫測定/免疫化学
  • 分子診断学
  • 血液学
  • 尿検査
  • その他

用途

  • 心臓病学
  • 糖尿病
  • 腫瘍学
  • 感染症
  • 腎臓内科
  • 自己免疫疾患
  • 医薬品検査／ファーマコゲノミクス
  • その他

エンドユーザー

  • 学術・研究機関
  • 診断研究所
  • 病院
  • その他

世界市場全体と各分野の売上予測に加え、5つの地域と20の主要国市場の売上予測も掲載しています：

北米

  • 米国
  • カナダ

欧州

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州地域

アジア太平洋

  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • その他のアジア太平洋地域

ラテンアメリカ

  • ブラジル
  • メキシコ
  • その他のラテンアメリカ地域

MEA

  • GCC
  • 南アフリカ
  • その他のMEA地域

体外診断薬市場レポート 2025-2035

本レポートでは、体外診断薬市場の2025年から2035年にかけての主要企業のプロファイルも掲載しており、これらの企業の事業のこのセグメントに焦点を当てている。

主要企業と市場成長の可能性

  • QIAGEN
  • BD
  • BioMérieux
  • F. Hoffmann-La Roche, Ltd.
  • Quidel
  • Ortho Corporation
  • Abbott
  • Agilent Technologies, Inc.
  • Thermofisher Scientific, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Sysmex Corporation
  • Charles River Laboratories
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • Hologic
  • Revvity
  • Exact Sciences

体外診断薬市場全体の世界売上高、2025年から2035年まで、金額ベースでは2025年に950億米ドルを突破するとの計算。2035年まで力強い収益成長を予測。当社の調査では、最も大きな可能性を秘めた組織を特定しています。彼らの能力、進歩、商業的展望を発見し、あなたが一歩先を行くのを支援します。

体外診断薬市場、2025-2035年レポートはどのようにお役に立ちますか？

要約すると、350ページを超えるこのレポートは、以下の知識を提供する：

  • 体外診断薬市場の2025年から2035年までの収益予測、製品、検査、用途、エンドユーザー別の予測を世界と地域レベルで掲載 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけることができます。
  • 5つの地域と20の主要国市場の2035年までの収益予測 - 体外診断薬市場、北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEAの2025年から2035年までの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの著名経済圏の市場も予測しています。
  • 2025年から2035年までの体外診断薬市場に関わる主要企業19社の企業プロファイルを含む、既存企業および市場参入を目指す企業の展望。

独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を入手しましょう。

 


ページTOPに戻る


目次

1 レポート概要
1.1 研究の目的
1.2 体外診断薬市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問は以下の通り：
1.6 本レポートの対象者
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブ・サマリー

3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.3 影響分析
3.3.1 市場促進要因
3.3.1.1 先端技術の導入
3.3.1.2 老年人口の増加
3.3.1.3 PoC検査の需要増加
3.3.2 市場抑制要因
3.3.2.1 診断機器の高コスト
3.3.2.2 IVDにおける厳しい規制要件
3.3.3 市場機会
3.3.3.1 免疫測定診断技術の向上
3.3.3.2 新興市場での拡大
3.3.3.3 在宅検査とポイントオブケア検査の成長
3.4 米国の関税：世界の体外診断薬市場への影響は？
3.4.1 概要
3.4.2 V字回復シナリオ
3.4.3 なぜV字回復なのか？
3.4.3.1 関税による影響
3.4.3.2 市場ダイナミクスと需要回復
3.4.3.3 政策と資金援助
3.4.3.4 回復のタイムフレーム
3.4.4 U字型回復シナリオ
3.4.4.1 なぜU字型回復なのか？
3.4.4.2 関税による影響
3.4.4.3 市場ダイナミクスと需要回復
3.4.4.4 政策と資金援助
3.4.4.5 回復のタイムフレーム
3.4.5 L字型回復シナリオ
3.4.5.1 なぜL字型回復なのか？
3.4.5.2 関税による影響
3.4.5.3 市場ダイナミクスと需要回復
3.4.5.4 政策と資金援助
3.4.5.5 回復のタイムフレーム
3.4.6 顧客が短期（2025 - 2030年）および長期（2025 - 2035年）計画に織り込むべき戦略的考慮事項とは？
3.4.7 米中貿易戦争が体外診断薬市場に与える影響
3.4.8 最も影響を受ける国は、これらの政策変更によってどのようなプラス効果とマイナス効果を経験するか？
3.4.9 貿易関税の影響に関する感度マッピング
3.5 ポーターのファイブフォース分析
3.5.1 サプライヤーの交渉力
3.5.2 買い手の交渉力
3.5.3 競争力
3.5.4 代替品の脅威
3.5.5 新規参入企業の脅威
3.6 PEST分析
3.6.1 政治的要因
3.6.2 経済
3.6.3 社会
3.6.4 技術的
3.7 トランプ関税の体外診断薬市場への影響
3.7.1 貿易障壁とサプライチェーンの混乱
3.7.2 米国および世界のメーカーへのコストへの影響
3.7.3 政策の不確実性と投資の躊躇

4 体外診断薬市場分析：製品別
4.1 主要な調査結果
4.2 製品セグメント市場魅力度指数
4.3 体外診断薬の製品別市場規模予測と予測
4.4 機器
4.4.1 2025〜2035年の地域別市場予測（10億米ドル、AGR）
4.4.2 地域別市場シェア、2025年〜2035年(%)
4.5 試薬・キット
4.5.1 2025〜2035年地域別市場予測（10億米ドル、AGR）
4.5.2 地域別市場シェア、2025年〜2035年(%)

5 体外診断薬市場分析：検査別
5.1 主要な調査結果
5.2 検査セグメント 市場魅力度指数
5.3 体外診断薬の検査別市場規模の推定と予測
5.4 臨床化学
5.4.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.4.2 地域別市場シェア、2025年〜2035年(%)
5.5 免疫測定／免疫化学
5.5.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.5.2 地域別市場シェア、2025年〜2035年(%)
5.6 分子診断薬
5.6.1 2025〜2035年の地域別市場予測（10億米ドル、AGR）
5.6.2 地域別市場シェア、2025年〜2035年(%)
5.7 血液学
5.7.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.7.2 地域別市場シェア、2025年〜2035年(%)
5.8 尿検査
5.8.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.8.2 地域別市場シェア、2025年〜2035年(%)
5.9 その他
5.9.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.9.2 地域別市場シェア、2025年〜2035年(%)

6 体外診断薬市場分析：用途別
6.1 主要な調査結果
6.2 用途セグメント 市場魅力度指数
6.3 体外診断薬の用途別市場規模推定と予測
6.4 循環器内科
6.4.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
6.4.2 地域別市場シェア、2025年〜2035年(%)
6.5 糖尿病
6.5.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
6.5.2 地域別市場シェア、2025年〜2035年(%)
6.6 がん領域
6.6.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
6.6.2 地域別市場シェア、2025年〜2035年(%)
6.7 感染症
6.7.1 2025〜2035年の地域別市場予測（10億米ドル、AGR）
6.7.2 地域別市場シェア、2025年〜2035年(%)
6.8 母体疾患
6.8.1 2025〜2035年の地域別市場予測（10億米ドル、AGR）
6.8.2 地域別市場シェア、2025年〜2035年(%)
6.9 移動障害
6.9.1 2025〜2035年の地域別市場予測（10億米ドル、AGR）
6.9.2 地域別市場シェア、2025年〜2035年(%)
6.10 自己免疫疾患
6.10.1 地域別市場予測、2025〜2035年（10億米ドル、AGR %)
6.10.2 地域別市場シェア、2025年〜2035年(%)
6.11 薬物検査／ファーマコゲノミクス
6.11.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
6.11.2 地域別市場シェア、2025年〜2035年(%)
6.12 その他
6.12.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
6.12.2 地域別市場シェア、2025年〜2035年(%)

7 体外診断薬市場分析：エンドユーザー別
7.1 主要な調査結果
7.2 エンドユーザーセグメント： 市場魅力度指数
7.3 体外診断薬のエンドユーザー別市場規模推定と予測
7.4 学術・研究機関
7.4.1 地域別市場予測、2025年～2035年（10億米ドル、AGR %)
7.4.2 地域別市場シェア、2025年〜2035年(%)
7.5 診断研究所
7.5.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
7.5.2 地域別市場シェア、2025年〜2035年(%)
7.6 病院
7.6.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
7.6.2 地域別市場シェア、2025年〜2035年(%)
7.7 その他
7.7.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
7.7.2 地域別市場シェア、2025年〜2035年(%)

8 体外診断薬市場分析：地域別
8.1 主要な調査結果
8.2 地域別市場規模の推定と予測

9 北米の体外診断薬市場分析
9.1 主要な調査結果
9.2 北米の体外診断薬市場魅力度指数
9.3 北米の体外診断薬市場国別、2025年、2030年、2035年（10億米ドル）
9.4 北米の体外診断薬の国別市場規模推定と予測
9.5 北米の体外診断薬市場規模推定と予測：製品別
9.6 北米の体外診断薬市場規模推定と予測：検査別
9.7 北米の体外診断薬市場規模推定と予測：用途別
9.8 北米の体外診断薬市場規模推定と予測：エンドユーザー別
9.9 アメリカの体外診断薬市場分析
9.10 カナダの体外診断薬市場分析

10 欧州の体外診断薬市場分析
10.1 主要な調査結果
10.2 欧州の体外診断薬市場魅力度指数
10.3 欧州の体外診断薬市場：国別、2025年、2030年、2035年（10億米ドル）
10.4 欧州の体外診断薬国別市場規模推定と予測
10.5 欧州の体外診断薬市場規模推定と予測：製品別
10.6 欧州の体外診断薬市場規模推定と予測：検査別
10.7 欧州の体外診断薬市場規模推定と予測：用途別
10.8 欧州の体外診断薬市場規模推定と予測：エンドユーザー別
10.9 ドイツの体外診断薬市場分析
10.10 イギリスの体外診断薬市場分析
10.11 フランスの体外診断薬市場分析
10.12 イタリアの体外診断薬市場分析
10.13 スペインの体外診断薬市場分析
10.14 その他の欧州の体外診断薬市場分析

11 アジア太平洋地域の体外診断薬市場分析
11.1 主要な調査結果
11.2 アジア太平洋地域の体外診断薬市場魅力度指数
11.3 アジア太平洋地域の体外診断薬市場国別、2025年、2030年、2035年（10億米ドル）
11.4 アジア太平洋地域の体外診断薬国別市場規模推定と予測
11.5 アジア太平洋地域の体外診断薬市場規模推定と予測：製品別
11.6 アジア太平洋地域の体外診断薬市場規模推定と予測：検査別
11.7 アジア太平洋地域の体外診断薬市場規模推定と予測：用途別
11.8 アジア太平洋地域の体外診断薬市場規模推定と予測：エンドユーザー別
11.9 日本の体外診断薬市場分析
11.10 中国の体外診断薬市場分析
11.11 インドの体外診断薬市場分析
11.12 オーストラリアの体外診断薬市場分析
11.13 その他のアジア太平洋地域の体外診断薬市場分析

12 ラテンアメリカの体外診断薬市場分析
12.1 主要な調査結果
12.2 ラテンアメリカ体外診断薬市場魅力度指数
12.3 ラテンアメリカの体外診断薬市場国別、2025年、2030年、2035年（10億米ドル）
12.4 ラテンアメリカの体外診断薬国別市場規模推定と予測
12.5 ラテンアメリカの体外診断薬市場規模推定と予測：製品別
12.6 ラテンアメリカの体外診断薬市場規模推定と予測：検査別
12.7 ラテンアメリカの体外診断薬市場規模推定と予測：用途別
12.8 ラテンアメリカの体外診断薬市場規模推定と予測：エンドユーザー別
12.9 ブラジルの体外診断薬市場分析
12.10 メキシコの体外診断薬市場分析
12.11 その他のラテンアメリカの体外診断薬市場分析

13 MEAの体外診断薬市場分析
13.1 主要な調査結果
13.2 MEAの体外診断薬市場魅力度指数
13.3 MEAの体外診断薬の国別市場、2025年、2030年、2035年（10億米ドル）
13.4 MEAの体外診断薬国別市場規模推定と予測
13.5 MEAの体外診断薬市場規模推定と予測：製品別
13.6 MEAの体外診断薬市場規模推定と予測：検査別
13.7 MEAの体外診断薬市場規模推定と予測：用途別
13.8 MEAの体外診断薬市場規模推定と予測：エンドユーザー別
13.9 GCCの体外診断薬市場分析
13.10 南アフリカの体外診断薬市場の分析
13.11 その他のMEA体外診断薬市場の分析

14 主要企業のプロファイル
14.1 QIAGEN
14.1.1 会社概要
14.1.2 会社概要
14.1.3 財務分析
14.1.3.1 純収入、2020-2024年
14.1.3.2 R＆D、2020-2024年
14.1.3.3 地域市場シェア、2024年
14.1.3.4 事業セグメント市場シェア（2024年
14.1.4 製品ベンチマーク
14.1.5 SWOT分析
14.1.6 戦略的展望
14.2 BD
14.2.1 会社概要
14.2.2 会社概要
14.2.3 財務分析
14.2.3.1 純収入、2020-2024年
14.2.3.2 R＆D、2020-2024年
14.2.3.3 事業セグメント市場シェア、2024年
14.2.4 製品ベンチマーク
14.2.5 SWOT分析
14.3 BIOMÉRIEUX
14.3.1 会社概要
14.3.2 会社概要
14.3.3 財務分析
14.3.3.1 純収入、2020-2024年
14.3.3.2 R＆D、2020-2024年
14.3.3.3 地域市場シェア、2024年
14.3.4 製品ベンチマーク
14.3.5 SWOT分析
14.3.6 戦略的展望
14.4 F. Hoffmann-La Roche, Ltd.
14.4.1 会社概要
14.4.2 会社概要
14.4.3 財務分析
14.4.3.1 純収入、2020-2024年
14.4.3.2 R＆D、2020-2024年
14.4.3.3 事業セグメント市場シェア、2024年
14.4.4 製品ベンチマーク
14.4.5 SWOT分析
14.4.6 戦略的展望
14.5 QuidelOrtho Corporation
14.5.1 会社概要
14.5.2 会社概要
14.5.3 財務分析
14.5.3.1 純収入、2020-2024年
14.5.3.2 R＆D、2020-2024年
14.5.3.3 地域市場シェア、2024年
14.5.3.4 事業セグメント市場シェア（2024年
14.5.4 製品ベンチマーク
14.5.5 SWOT分析
14.5.6 戦略的展望
14.6 Abbott
14.6.1 会社概要
14.6.2 会社概要
14.6.3 財務分析
14.6.3.1 純収入、2020-2024年
14.6.3.2 R＆D、2020-2024年
14.6.3.3 地域市場シェア、2024年
14.6.3.4 事業セグメント市場シェア（2024年
14.6.4 製品ベンチマーク
14.7 Agilent Technologies, Inc.
14.7.1 会社概要
14.7.2 会社概要
14.7.3 財務分析
14.7.3.1 純収入、2020-2024年
14.7.3.2 R＆D、2020-2024年
14.7.3.3 地域市場シェア、2024年
14.7.3.4 事業セグメント市場シェア（2024年
14.7.4 製品ベンチマーク
14.7.5 戦略的展望
14.8 Thermofisher Scientific, Inc.
14.8.1 会社概要
14.8.2 会社概要
14.8.3 財務分析
14.8.3.1 純収入、2020-2024年
14.8.3.2 売上高、2020-2024年
14.8.3.3 地域市場シェア、2024年
14.8.3.4 事業セグメント市場シェア（2024年
14.8.4 製品ベンチマーク
14.8.5 戦略的展望
14.9 Siemens Healthineers AG
14.9.1 会社概要
14.9.2 会社概要
14.9.3 財務分析
14.9.3.1 純収入、2020-2024年
14.9.3.2 地域別市場シェア（2024年
14.9.3.3 事業セグメント市場シェア（2024年
14.9.4 製品ベンチマーク
14.9.5 戦略的展望
14.10 Bio-Rad Laboratories, Inc.
14.10.1 会社概要
14.10.2 会社概要
14.10.3 財務分析
14.10.3.1 純収入、2020-2024年
14.10.3.2 地域市場シェア、2024年
14.10.3.3 事業セグメント市場シェア、2024年
14.10.4 製品ベンチマーク
14.10.5 戦略的展望
14.11 Danaher
14.11.1 会社概要
14.11.2 会社概要
14.11.3 財務分析
14.11.3.1 純収入、2020-2024年
14.11.3.2 売上高、2020-2024年
14.11.3.3 地域市場シェア、2024年
14.11.3.4 事業セグメント市場シェア（2024年
14.11.4 製品ベンチマーク
14.11.5 戦略的展望
14.12 Sysmex Corporation
14.12.1 会社概要
14.12.2 会社概要
14.12.3 財務分析
14.12.3.1 純収入、2020-2024年
14.12.3.2 売上高、2020-2024年
14.12.4 製品ベンチマーク
14.12.5 戦略的展望
14.13 Charles River Laboratories
14.13.1 会社概要
14.13.2 会社概要
14.13.3 財務分析
14.13.3.1 純収入、2020-2024年
14.13.3.2 地域市場シェア、2024年
14.13.3.3 事業セグメント市場シェア（2024年
14.13.4 サービスのベンチマーク
14.14 Quest Diagnostics Incorporated
14.14.1 会社概要
14.14.2 会社概要
14.14.3 財務分析
14.14.3.1 純収入、2020-2024年
14.14.3.2 事業セグメント市場シェア、2024年
14.14.4 製品ベンチマーク
14.14.5 戦略的展望
14.15 Illumina, Inc.
14.15.1 会社概要
14.15.2 会社概要
14.15.3 財務分析
14.15.3.1 純収入、2020-2024年
14.15.3.2 R＆D、2020-2024年
14.15.3.3 地域市場シェア、2024年
14.15.3.4 事業セグメント市場シェア（2024年
14.15.4 製品ベンチマーク
14.15.5 戦略的展望
14.16 Hologic
14.16.1 会社概要
14.16.2 会社概要
14.16.3 財務分析
14.16.3.1 純収入、2020-2024年
14.16.3.2 売上高、2020-2024年
14.16.3.3 地域市場シェア、2024年
14.16.3.4 事業セグメント市場シェア（2024年
14.16.4 製品ベンチマーク
14.16.5 戦略的展望
14.17 Exact Sciences
14.17.1 会社概要
14.17.2 会社概要
14.17.3 財務分析
14.17.3.1 純収入、2020-2024年
14.17.3.2 売上高、2020-2024年
14.17.3.3 地域市場シェア、2024年
14.17.4 製品ベンチマーク
14.18 Revvity
14.18.1 会社概要
14.18.2 会社概要
14.18.3 財務分析
14.18.3.1 純収入、2020-2024年
14.18.3.2 売上高、2020-2024年
14.18.4 製品ベンチマーク
14.18.5 戦略的展望

15 結論と提言
15.1 ビジョンゲインの結語
15.2 市場プレイヤーへの提言

ページTOPに戻る



図表リスト

List of Tables
Table 1 In Vitro Diagnostics Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 2 In Vitro Diagnostics Market: International Trade Tariff Impact Recovery Scenarios Snapshot
Table 3 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
Table 4 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
Table 5 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
Table 6 In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 7 Instruments Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 Reagents & Kits Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 10 Clinical Chemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 11 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Molecular Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Haematology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 Urinalysis Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Cardiology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 Diabetes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 21 Maternal Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Mobility Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Autoimmune Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 24 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Diagnostic Segment Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 27 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 28 Diagnostic Laboratories Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 29 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 30 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 31 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 32 North America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 33 North America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 34 North America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 35 North America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 36 North America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 U.S. In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 38 Canada In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 39 Europe In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 Europe In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 Europe In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 42 Europe In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 43 Europe In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 44 Germany In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 45 UK In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 46 France In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 47 Italy In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 48 Spain In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 49 Rest of Europe In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 50 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 53 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 54 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 55 Japan In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 China In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 57 India In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 58 Australia In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 59 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 60 Latin America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 61 Latin America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Latin America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 63 Latin America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 65 Brazil In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 66 Mexico In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 67 Rest of Latin America In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 68 MEA In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 69 MEA In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 70 MEA In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 71 MEA In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 72 MEA In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 73 GCC Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 74 South Africa Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 75 Rest of MEA Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 76 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 QIAGEN: Product Benchmarking
Table 78 QIAGEN: SWOT Analysis
Table 79 QIAGEN: Strategic Outlook
Table 80 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 BD: Product Benchmarking
Table 82 BD: SWOT Analysis
Table 83 BIOMÉRIEUX: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 BIOMÉRIEUX: Product Benchmarking
Table 85 BIOMÉRIEUX: SWOT Analysis
Table 86 BIOMÉRIEUX: Strategic Outlook
Table 87 F. Hoffmann-La Roche, Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 F. Hoffmann-La Roche, Ltd.: Product Benchmarking
Table 89 F. Hoffmann-La Roche, Ltd.: SWOT Analysis
Table 90 F. Hoffmann-La Roche, Ltd.: Strategic Outlook
Table 91 QuidelOrtho Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 QuidelOrtho Corporation: Product Benchmarking
Table 93 QuidelOrtho Corporation: SWOT Analysis
Table 94 QuidelOrtho Corporation: Strategic Outlook
Table 95 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Abbott: Product Benchmarking
Table 97 Agilent Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Agilent Technologies, Inc.: Product Benchmarking
Table 99 Agilent Technologies, Inc.: Strategic Outlook
Table 100 Thermofisher Scientific, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Thermofisher Scientific, Inc.: Product Benchmarking
Table 102 Thermofisher Scientific, Inc.: Strategic Outlook
Table 103 Siemens Healthineers AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Siemens Healthineers AG: Product Benchmarking
Table 105 Siemens Healthineers AG: Strategic Outlook
Table 106 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Bio-Rad Laboratories, Inc.: Product Benchmarking
Table 108 Bio-Rad Laboratories, Inc.: Strategic Outlook
Table 109 Danaher: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Danaher: Product Benchmarking
Table 111 Danaher: Strategic Outlook
Table 112 Sysmex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Sysmex Corporation: Product Benchmarking
Table 114 Sysmex Corporation: Strategic Outlook
Table 115 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Charles River Laboratories: Services Benchmarking
Table 117 Quest Diagnostics Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Quest Diagnostics Incorporated: Product Benchmarking
Table 119 Quest Diagnostics Incorporated: Strategic Outlook
Table 120 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Illumina, Inc.: Product Benchmarking
Table 122 Illumina, Inc.: Strategic Outlook
Table 123 Hologic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Hologic: Product Benchmarking
Table 125 Hologic: Strategic Outlook
Table 126 Exact Sciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Exact Sciences: Product Benchmarking
Table 128 Revvity: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Revvity: Product Benchmarking
Table 130 Revvity: Strategic Outlook

List of Figures
Figure 1 In Vitro Diagnostics Market Segmentation
Figure 2 In Vitro Diagnostics Market by Product: Market Attractiveness Index
Figure 3 In Vitro Diagnostics Market by Test: Market Attractiveness Index
Figure 4 In Vitro Diagnostics Market by Application: Market Attractiveness Index
Figure 5 In Vitro Diagnostics Market by End-users: Market Attractiveness Index
Figure 6 In Vitro Diagnostics Market Attractiveness Index by Region
Figure 7 In Vitro Diagnostics Market: Market Dynamics
Figure 8 In Vitro Diagnostics Market: Impact Analysis
Figure 9 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 10 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 11 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 12 Short Term & Long Term Planning
Figure 13 Impact of U.S. and China Trade War
Figure 14 Most Impacted Countries
Figure 15 Sensitivity Mapping for Tariff Impact
Figure 16 In Vitro Diagnostics Market: Porter’s Five Forces Analysis
Figure 17 In Vitro Diagnostics Market: PEST Analysis
Figure 18 In Vitro Diagnostics Market Attractiveness Index by Product
Figure 19 In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 20 In Vitro Diagnostics Market Share Forecast by Product, 2025, 2030, 2035 (%)
Figure 21 Instruments Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 22 Instruments Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 23 Reagents & Kits Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 24 Reagents & Kits Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 25 In Vitro Diagnostics Market Attractiveness Index by Product
Figure 26 In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 27 In Vitro Diagnostics Market Share Forecast by Test, 2025, 2030, 2035 (%)
Figure 28 Clinical Chemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 29 Clinical Chemistry Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 30 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 31 Immunoassay/Immunochemistry Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 32 Molecular Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 33 Molecular Diagnostics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 34 Haematology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 35 Haematology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 36 Urinalysis Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 37 Urinalysis Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 38 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 39 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 In Vitro Diagnostics Market Attractiveness Index by Application
Figure 41 In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 42 In Vitro Diagnostics Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 43 Cardiology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 Cardiology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 45 Diabetes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 46 Diabetes Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 47 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 48 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 49 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 50 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 51 Maternal Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 52 Maternal Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 53 Mobility Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 54 Mobility Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 55 Autoimmune Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 56 Autoimmune Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 57 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 58 Drug Testing/Pharmacogenomics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 59 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 60 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 61 In Vitro Diagnostics Market Attractiveness Index by End-users
Figure 62 In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 63 In Vitro Diagnostics Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 64 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 65 Academic & Research Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 66 Diagnostic Laboratories Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 67 Diagnostic Laboratories Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 68 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 69 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 70 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 71 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 72 In Vitro Diagnostics Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
Figure 73 In Vitro Diagnostics Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 74 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Mn)
Figure 75 North America In Vitro Diagnostics Market Attractiveness Index
Figure 76 North America In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 77 North America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 78 North America In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 79 North America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 80 North America In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 81 North America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 82 North America In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 83 North America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 84 North America In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 85 North America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 86 North America In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 87 U.S. In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 88 Canada In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 89 Europe In Vitro Diagnostics Market Attractiveness Index
Figure 90 Europe In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 91 Europe In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 92 Europe In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 93 Europe In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 94 Europe In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 95 Europe In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 96 Europe In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 97 Europe In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 98 Europe In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 99 Europe In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 100 Europe In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 101 Germany In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 102 UK In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 103 France In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 104 Italy In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 105 Spain In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 106 Rest of Europe In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 107 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
Figure 108 Asia Pacific In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 109 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 110 Asia Pacific In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 111 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 112 Asia Pacific In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 113 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 114 Asia Pacific In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 115 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 116 Asia Pacific In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 117 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 118 Asia Pacific In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 119 Japan In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 120 China In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 121 India In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 122 Australia In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 123 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 124 Latin America In Vitro Diagnostics Market Attractiveness Index
Figure 125 Latin America In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 126 Latin America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 127 Latin America In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 128 Latin America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 129 Latin America In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 130 Latin America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 131 Latin America In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 132 Latin America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 133 Latin America In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 134 Latin America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 135 Latin America In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 136 Brazil In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 137 Mexico In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 138 Rest of Latin America In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 139 MEA In Vitro Diagnostics Market Attractiveness Index
Figure 140 MEA In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 141 MEA In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 142 MEA In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 143 MEA In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 144 MEA In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 145 MEA In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 146 MEA In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 147 MEA In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 148 MEA In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 149 MEA In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 150 MEA In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 151 GCC In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 152 South Africa In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 153 Rest of MEA In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 154 QIAGEN: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 155 QIAGEN: R&D, 2020-2024 (US$ Million, AGR %)
Figure 156 QIAGEN: Regional Market Shares (%), 2024
Figure 157 QIAGEN: Business Segment Market Shares (%), 2024
Figure 158 BD: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 159 BD: R&D, 2020-2024 (US$ Million, AGR %)
Figure 160 BD: Business Segment Market Shares (%), 2024
Figure 161 BIOMÉRIEUX: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 162 BIOMÉRIEUX: R&D, 2020-2024 (US$ Million, AGR %)
Figure 163 BIOMÉRIEUX: Regional Market Shares (%), 2024
Figure 164 F. Hoffmann-La Roche, Ltd.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 165 F. Hoffmann-La Roche, Ltd.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 166 F. Hoffmann-La Roche, Ltd.: Business Segment Market Shares (%), 2024
Figure 167 QuidelOrtho Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 168 QuidelOrtho Corporation: R&D, 2020-2024 (US$ Million, AGR %)
Figure 169 QuidelOrtho Corporation: Regional Market Shares (%), 2024
Figure 170 QuidelOrtho Corporation: Business Segment Market Shares (%), 2024
Figure 171 Abbott: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 172 Abbott: R&D, 2020-2024 (US$ Million, AGR %)
Figure 173 Abbott: Regional Market Shares (%), 2024
Figure 174 Abbott: Business Segment Market Shares (%), 2024
Figure 175 Agilent Technologies, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 176 Agilent Technologies, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 177 Agilent Technologies, Inc.: Regional Market Shares (%), 2024
Figure 178 Agilent Technologies, Inc.: Business Segment Market Shares (%), 2024
Figure 179 Thermofisher Scientific, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 180 Thermofisher Scientific, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 181 Thermofisher Scientific, Inc.: Regional Market Shares (%), 2024
Figure 182 Thermofisher Scientific, Inc.: Business Segment Market Shares (%), 2024
Figure 183 Siemens Healthineers AG: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 184 Siemens Healthineers AG: Regional Market Shares (%), 2024
Figure 185 Siemens Healthineers AG: Business Segment Market Shares (%), 2024
Figure 186 Bio-Rad Laboratories, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 187 Bio-Rad Laboratories, Inc.: Regional Market Shares (%), 2024
Figure 188 Bio-Rad Laboratories, Inc.: Business Segment Market Shares (%), 2024
Figure 189 Danaher: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 190 Danaher: R&D, 2020-2024 (US$ Million, AGR %)
Figure 191 Danaher: Regional Market Shares (%), 2024
Figure 192 Danaher: Business Segment Market Shares (%), 2024
Figure 193 Sysmex Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 194 Sysmex Corporation: R&D, 2020-2024 (US$ Million, AGR %)
Figure 195 Charles River Laboratories: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 196 Charles River Laboratories: Regional Market Shares (%), 2024
Figure 197 Charles River Laboratories: Business Segment Market Shares (%), 2024
Figure 198 Quest Diagnostics Incorporated: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 199 Quest Diagnostics Incorporated: Business Segment Market Shares (%), 2024
Figure 200 Illumina, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 201 Illumina, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 202 Illumina, Inc.: Regional Market Shares (%), 2024
Figure 203 Illumina, Inc.: Business Segment Market Shares (%), 2024
Figure 204 Hologic: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 205 Hologic: R&D, 2020-2024 (US$ Million, AGR %)
Figure 206 Hologic: Regional Market Shares (%), 2024
Figure 207 Hologic: Business Segment Market Shares (%), 2024
Figure 208 Exact Sciences: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 209 Exact Sciences: R&D, 2020-2024 (US$ Million, AGR %)
Figure 210 Exact Sciences: Regional Market Shares (%), 2024
Figure 211 Revvity: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 212 Revvity: R&D, 2020-2024 (US$ Million, AGR %)

　

ページTOPに戻る


　

Summary

Description

The In Vitro Diagnostics Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Technological Advancements Propelling Industry Growth

The in-vitro diagnostics (IVD) sector continues to experience significant growth, propelled by advancements in diagnostic technologies that enhance precision, portability, and affordability. A notable milestone was achieved in May 2025 when the U.S. Food and Drug Administration (FDA) approved the first blood test to aid in diagnosing Alzheimer’s disease. Developed by Fujirebio Diagnostics, the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test measures specific biomarkers associated with Alzheimer’s, offering a less invasive and more accessible alternative to traditional diagnostic methods like PET scans and spinal taps. This approval is expected to improve early detection and management of Alzheimer’s disease, particularly benefiting the aging population .

In parallel, the oncology diagnostics landscape is being transformed by the adoption of blood-based tests for detecting minimal residual disease (MRD). Companies such as Guardant Health, Natera, and Exact Sciences are at the forefront of this revolution, utilising circulating tumour DNA to identify cancer recurrences much earlier than conventional imaging methods. These advancements enable more timely interventions and personalised treatment strategies, marking a significant shift in cancer care .

Segment Analysis

As of 2025, the reagents segment maintains its dominance in the IVD market, accounting for over 60% of the market share. This segment is projected to exhibit the highest compound annual growth rate (CAGR) through 2035, driven by continuous innovation and the development of novel diagnostic reagents and kits. A recent example includes the FDA’s clearance of Werfen’s Aptiva reagents for enhanced autoimmune diagnostics. These reagents offer improved specificity and efficiency in detecting autoimmune diseases, reflecting the industry’s commitment to advancing diagnostic accuracy.

Furthermore, the demand for personalised medicine is fuelling the growth of companion diagnostics. In January 2025, Tempus AI, Inc. announced the national launch of its FDA-approved, next-generation sequencing (NGS)-based in vitro diagnostic device, xT CDx. This comprehensive test provides insights into a wide array of genetic alterations, aiding clinicians in selecting targeted therapies for cancer patients. The integration of such advanced diagnostics into clinical practice underscores the critical role of reagents in enabling precision medicine .

As the IVD industry continues to evolve, investments in research and development of innovative reagents and diagnostic tools remain pivotal. Companies focusing on these areas are well-positioned to lead in the competitive landscape, addressing emerging healthcare needs with cutting-edge solutions.

What would be the Impact of US Trade Tariffs on the Global In Vitro Diagnostics Market?

The influence of U.S. trade tariffs on the global In Vitro Diagnostics (IVD) market can be substantial, affecting cost structures and supply chain dynamics across various regions. A multitude of in vitro diagnostic (IVD) products, encompassing reagents, analysers, and components, are imported into the United States from nations such as China, Germany, and Japan. Tariffs on these imports can increase the cost of goods sold for U.S.-based diagnostics firms, potentially compressing profit margins or resulting in elevated prices for healthcare providers and patients.

The global ripple effect encompasses supply chain realignment, as companies may relocate sourcing or manufacturing to tariff-exempt nations, thereby augmenting operational complexity and expenses. Moreover, uncertainty surrounding tariffs may postpone investments in innovation or international collaborations, especially for small and medium-sized IVD companies dependent on global partnerships. In areas such as the EU and Asia-Pacific, this could create opportunities to enhance domestic production or secure a competitive advantage in exports to non-U.S. markets. In the long term, enduring tariffs may expedite localisation strategies, cultivate regional alliances, and transform the competitive dynamics of the global IVD industry.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the in vitro diagnostics market evolving?
  • What is driving and restraining the in vitro diagnostics market?
  • How will each in vitro diagnostics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each in vitro diagnostics submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading in vitro diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the in vitro diagnostics projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035?
  • What are the implications of
    in vitro diagnostics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the in vitro diagnostics market?
  • Where is the in vitro diagnostics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the in vitro diagnostics market today, and over the next 10 years:

  • Our 356-page report provides 125 tables, 212 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Product

  • Instruments
  • Reagents & Kits

Test

  • Clinical Chemistry
  • Immunoassay/Immunochemistry
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Others

Application

  • Cardiology
  • Diabetes
  • Oncology
  • Infectious Diseases
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing/Pharmacogenomics
  • Others

End-users

  • Academic & Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

In Vitro Diagnostics Market Report 2025-2035

The report also includes profiles for some of the leading companies in the In Vitro Diagnostics Market, 2025 to 2035, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • QIAGEN
  • BD
  • BioMérieux
  • F. Hoffmann-La Roche, Ltd.
  • Quidel
  • Ortho Corporation
  • Abbott
  • Agilent Technologies, Inc.
  • Thermofisher Scientific, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Sysmex Corporation
  • Charles River Laboratories
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • Hologic
  • Revvity
  • Exact Sciences

Overall world revenue for In Vitro Diagnostics Market, 2025 to 2035 in terms of value the market will surpass US$95 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the In Vitro Diagnostics Market, 2025 to 2035 report help you?

In summary, our 350+ page report provides you with the following knowledge:

  • Revenue forecasts to 2035 for In Vitro Diagnostics Market 2025 to 2035, with forecasts for Product, Test, Application, and End-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 20 key national markets – See forecasts for the In Vitro Diagnostics Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 19 of the major companies involved in the In Vitro Diagnostics Market, 2025 to 2035.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

 



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to In Vitro Diagnostics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Introduction of Technologically Advanced Products
3.3.1.2 Rise in Geriatric Population
3.3.1.3 Increasing Demand of PoC Testing
3.3.2 Market Restraining Factors
3.3.2.1 High Cost of Diagnostic Equipment
3.3.2.2 Stringent Regulatory Requirements in IVD
3.3.3 Market Opportunities
3.3.3.1 Improvement in Immunoassay Diagnostic Technologies
3.3.3.2 Expansion in Emerging Markets
3.3.3.3 Growth of Home-based and Point-of-Care Testing
3.4 U.S. Tariffs: What’s the Impact on Global In Vitro Diagnostics Market?
3.4.1 Overview
3.4.2 V-Shaped Recovery Scenario
3.4.3 Why V-Shaped Recovery?
3.4.3.1 Impact from Tariffs
3.4.3.2 Market Dynamics and Demand Recovery
3.4.3.3 Policy and Funding Support
3.4.3.4 Timeframe for Recovery
3.4.4 U-Shaped Recovery Scenario
3.4.4.1 Why U-Shaped Recovery?
3.4.4.2 Impact from Tariffs
3.4.4.3 Market Dynamics and Demand Recovery
3.4.4.4 Policy and Funding Support
3.4.4.5 Timeframe for Recovery
3.4.5 L Shaped Recovery Scenario
3.4.5.1 Why L-Shaped Recovery?
3.4.5.2 Impact from Tariffs
3.4.5.3 Market Dynamics and Demand Recovery
3.4.5.4 Policy and Funding Support
3.4.5.5 Timeframe for Recovery
3.4.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025–2030) and Long-term (2025–2035) Planning?
3.4.7 Impact of U.S. and China Trade War on In Vitro Diagnostics Market
3.4.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.4.9 Sensitivity Mapping for the Trade Tariff Impact
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitutes
3.5.5 Threat of New Entrants
3.6 PEST Analysis
3.6.1 Political
3.6.2 Economical
3.6.3 Social
3.6.4 Technological
3.7 Impact of Trump Tariffs on In Vitro Diagnostics Market
3.7.1 Trade Barriers and Supply Chain Disruption
3.7.2 Cost Implications for U.S. and Global Manufacturers
3.7.3 Policy Uncertainty and Investment Hesitation

4 In Vitro Diagnostics Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 In Vitro Diagnostics Market Size Estimation and Forecast by Product
4.4 Instruments
4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.5 Reagents & Kits
4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2025 & 2035 (%)

5 In Vitro Diagnostics Market Analysis by Test
5.1 Key Findings
5.2 Test Segment: Market Attractiveness Index
5.3 In Vitro Diagnostics Market Size Estimation and Forecast by Test
5.4 Clinical Chemistry
5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Immunoassay/Immunochemistry
5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Molecular Diagnostics
5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.7 Haematology
5.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2025 & 2035 (%)
5.8 Urinalysis
5.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2025 & 2035 (%)
5.9 Others
5.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.9.2 Market Share by Region, 2025 & 2035 (%)

6 In Vitro Diagnostics Market Analysis by Application
6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.3 In Vitro Diagnostics Market Size Estimation and Forecast by Application
6.4 Cardiology
6.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Diabetes
6.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.5.2 Market Share by Region, 2025 & 2035 (%)
6.6 Oncology
6.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.6.2 Market Share by Region, 2025 & 2035 (%)
6.7 Infectious Diseases
6.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.7.2 Market Share by Region, 2025 & 2035 (%)
6.8 Maternal Disorders
6.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.8.2 Market Share by Region, 2025 & 2035 (%)
6.9 Mobility Disorders
6.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.9.2 Market Share by Region, 2025 & 2035 (%)
6.10 Autoimmune Diseases
6.10.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.10.2 Market Share by Region, 2025 & 2035 (%)
6.11 Drug Testing/Pharmacogenomics
6.11.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.11.2 Market Share by Region, 2025 & 2035 (%)
6.12 Others
6.12.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.12.2 Market Share by Region, 2025 & 2035 (%)

7 In Vitro Diagnostics Market Analysis by End-users
7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 In Vitro Diagnostics Market Size Estimation and Forecast by End-users
7.4 Academic & Research Institutes
7.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.5 Diagnostic Laboratories
7.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.5.2 Market Share by Region, 2025 & 2035 (%)
7.6 Hospitals
7.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.6.2 Market Share by Region, 2025 & 2035 (%)
7.7 Others
7.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.7.2 Market Share by Region, 2025 & 2035 (%)

8 In Vitro Diagnostics Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America In Vitro Diagnostics Market Analysis
9.1 Key Findings
9.2 North America In Vitro Diagnostics Market Attractiveness Index
9.3 North America In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
9.4 North America In Vitro Diagnostics Market Size Estimation and Forecast by Country
9.5 North America In Vitro Diagnostics Market Size Estimation and Forecast by Product
9.6 North America In Vitro Diagnostics Market Size Estimation and Forecast by Test
9.7 North America In Vitro Diagnostics Market Size Estimation and Forecast by Application
9.8 North America In Vitro Diagnostics Market Size Estimation and Forecast by End-users
9.9 U.S. In Vitro Diagnostics Market Analysis
9.10 Canada In Vitro Diagnostics Market Analysis

10 Europe In Vitro Diagnostics Market Analysis
10.1 Key Findings
10.2 Europe In Vitro Diagnostics Market Attractiveness Index
10.3 Europe In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
10.4 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Country
10.5 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Product
10.6 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Test
10.7 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Application
10.8 Europe In Vitro Diagnostics Market Size Estimation and Forecast by End-users
10.9 Germany In Vitro Diagnostics Market Analysis
10.10 UK In Vitro Diagnostics Market Analysis
10.11 France In Vitro Diagnostics Market Analysis
10.12 Italy In Vitro Diagnostics Market Analysis
10.13 Spain In Vitro Diagnostics Market Analysis
10.14 Rest of Europe In Vitro Diagnostics Market Analysis

11 Asia Pacific In Vitro Diagnostics Market Analysis
11.1 Key Findings
11.2 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
11.3 Asia Pacific In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
11.4 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Country
11.5 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Product
11.6 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Test
11.7 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Application
11.8 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by End-users
11.9 Japan In Vitro Diagnostics Market Analysis
11.10 China In Vitro Diagnostics Market Analysis
11.11 India In Vitro Diagnostics Market Analysis
11.12 Australia In Vitro Diagnostics Market Analysis
11.13 Rest of Asia Pacific In Vitro Diagnostics Market Analysis

12 Latin America In Vitro Diagnostics Market Analysis
12.1 Key Findings
12.2 Latin America In Vitro Diagnostics Market Attractiveness Index
12.3 Latin America In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
12.4 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Country
12.5 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Product
12.6 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Test
12.7 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Application
12.8 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by End-users
12.9 Brazil In Vitro Diagnostics Market Analysis
12.10 Mexico In Vitro Diagnostics Market Analysis
12.11 Rest of Latin America In Vitro Diagnostics Market Analysis

13 MEA In Vitro Diagnostics Market Analysis
13.1 Key Findings
13.2 MEA In Vitro Diagnostics Market Attractiveness Index
13.3 MEA In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
13.4 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Country
13.5 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Product
13.6 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Test
13.7 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Application
13.8 MEA In Vitro Diagnostics Market Size Estimation and Forecast by End-users
13.9 GCC In Vitro Diagnostics Market Analysis
13.10 South Africa In Vitro Diagnostics Market Analysis
13.11 Rest of MEA In Vitro Diagnostics Market Analysis

14 Company Profiles
14.1 QIAGEN
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.3.1 Net Revenue, 2020-2024
14.1.3.2 R&D, 2020-2024
14.1.3.3 Regional Market Shares, 2024
14.1.3.4 Business Segment Market Shares, 2024
14.1.4 Product Benchmarking
14.1.5 SWOT Analysis
14.1.6 Strategic Outlook
14.2 BD
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2020-2024
14.2.3.2 R&D, 2020-2024
14.2.3.3 Business Segment Market Shares, 2024
14.2.4 Product Benchmarking
14.2.5 SWOT Analysis
14.3 BIOMÉRIEUX
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2020-2024
14.3.3.2 R&D, 2020-2024
14.3.3.3 Regional Market Shares, 2024
14.3.4 Product Benchmarking
14.3.5 SWOT Analysis
14.3.6 Strategic Outlook
14.4 F. Hoffmann-La Roche, Ltd.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2020-2024
14.4.3.2 R&D, 2020-2024
14.4.3.3 Business Segment Market Shares, 2024
14.4.4 Product Benchmarking
14.4.5 SWOT Analysis
14.4.6 Strategic Outlook
14.5 QuidelOrtho Corporation
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2020-2024
14.5.3.2 R&D, 2020-2024
14.5.3.3 Regional Market Shares, 2024
14.5.3.4 Business Segment Market Shares, 2024
14.5.4 Product Benchmarking
14.5.5 SWOT Analysis
14.5.6 Strategic Outlook
14.6 Abbott
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2020-2024
14.6.3.2 R&D, 2020-2024
14.6.3.3 Regional Market Shares, 2024
14.6.3.4 Business Segment Market Shares, 2024
14.6.4 Product Benchmarking
14.7 Agilent Technologies, Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2020-2024
14.7.3.2 R&D, 2020-2024
14.7.3.3 Regional Market Shares, 2024
14.7.3.4 Business Segment Market Shares, 2024
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Thermofisher Scientific, Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2020-2024
14.8.3.2 R&D, 2020-2024
14.8.3.3 Regional Market Shares, 2024
14.8.3.4 Business Segment Market Shares, 2024
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 Siemens Healthineers AG
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2020-2024
14.9.3.2 Regional Market Shares, 2024
14.9.3.3 Business Segment Market Shares, 2024
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Bio-Rad Laboratories, Inc.
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2020-2024
14.10.3.2 Regional Market Shares, 2024
14.10.3.3 Business Segment Market Shares, 2024
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Danaher
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2020-2024
14.11.3.2 R&D, 2020-2024
14.11.3.3 Regional Market Shares, 2024
14.11.3.4 Business Segment Market Shares, 2024
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Sysmex Corporation
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2020-2024
14.12.3.2 R&D, 2020-2024
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 Charles River Laboratories
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2020-2024
14.13.3.2 Regional Market Shares, 2024
14.13.3.3 Business Segment Market Shares, 2024
14.13.4 Services Benchmarking
14.14 Quest Diagnostics Incorporated
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2020-2024
14.14.3.2 Business Segment Market Shares, 2024
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
14.15 Illumina, Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2020-2024
14.15.3.2 R&D, 2020-2024
14.15.3.3 Regional Market Shares, 2024
14.15.3.4 Business Segment Market Shares, 2024
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook
14.16 Hologic
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Net Revenue, 2020-2024
14.16.3.2 R&D, 2020-2024
14.16.3.3 Regional Market Shares, 2024
14.16.3.4 Business Segment Market Shares, 2024
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook
14.17 Exact Sciences
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.3.1 Net Revenue, 2020-2024
14.17.3.2 R&D, 2020-2024
14.17.3.3 Regional Market Shares, 2024
14.17.4 Product Benchmarking
14.18 Revvity
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.3.1 Net Revenue, 2020-2024
14.18.3.2 R&D, 2020-2024
14.18.4 Product Benchmarking
14.18.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1 In Vitro Diagnostics Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 2 In Vitro Diagnostics Market: International Trade Tariff Impact Recovery Scenarios Snapshot
Table 3 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
Table 4 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
Table 5 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
Table 6 In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 7 Instruments Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 Reagents & Kits Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 10 Clinical Chemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 11 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Molecular Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Haematology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 Urinalysis Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Cardiology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 Diabetes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 21 Maternal Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Mobility Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Autoimmune Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 24 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Diagnostic Segment Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 27 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 28 Diagnostic Laboratories Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 29 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 30 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 31 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 32 North America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 33 North America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 34 North America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 35 North America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 36 North America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 U.S. In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 38 Canada In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 39 Europe In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 Europe In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 Europe In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 42 Europe In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 43 Europe In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 44 Germany In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 45 UK In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 46 France In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 47 Italy In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 48 Spain In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 49 Rest of Europe In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 50 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 53 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 54 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 55 Japan In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 China In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 57 India In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 58 Australia In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 59 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 60 Latin America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 61 Latin America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Latin America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 63 Latin America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 65 Brazil In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 66 Mexico In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 67 Rest of Latin America In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 68 MEA In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 69 MEA In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 70 MEA In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 71 MEA In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 72 MEA In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 73 GCC Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 74 South Africa Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 75 Rest of MEA Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 76 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 QIAGEN: Product Benchmarking
Table 78 QIAGEN: SWOT Analysis
Table 79 QIAGEN: Strategic Outlook
Table 80 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 BD: Product Benchmarking
Table 82 BD: SWOT Analysis
Table 83 BIOMÉRIEUX: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 BIOMÉRIEUX: Product Benchmarking
Table 85 BIOMÉRIEUX: SWOT Analysis
Table 86 BIOMÉRIEUX: Strategic Outlook
Table 87 F. Hoffmann-La Roche, Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 F. Hoffmann-La Roche, Ltd.: Product Benchmarking
Table 89 F. Hoffmann-La Roche, Ltd.: SWOT Analysis
Table 90 F. Hoffmann-La Roche, Ltd.: Strategic Outlook
Table 91 QuidelOrtho Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 QuidelOrtho Corporation: Product Benchmarking
Table 93 QuidelOrtho Corporation: SWOT Analysis
Table 94 QuidelOrtho Corporation: Strategic Outlook
Table 95 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Abbott: Product Benchmarking
Table 97 Agilent Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Agilent Technologies, Inc.: Product Benchmarking
Table 99 Agilent Technologies, Inc.: Strategic Outlook
Table 100 Thermofisher Scientific, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Thermofisher Scientific, Inc.: Product Benchmarking
Table 102 Thermofisher Scientific, Inc.: Strategic Outlook
Table 103 Siemens Healthineers AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Siemens Healthineers AG: Product Benchmarking
Table 105 Siemens Healthineers AG: Strategic Outlook
Table 106 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Bio-Rad Laboratories, Inc.: Product Benchmarking
Table 108 Bio-Rad Laboratories, Inc.: Strategic Outlook
Table 109 Danaher: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Danaher: Product Benchmarking
Table 111 Danaher: Strategic Outlook
Table 112 Sysmex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Sysmex Corporation: Product Benchmarking
Table 114 Sysmex Corporation: Strategic Outlook
Table 115 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Charles River Laboratories: Services Benchmarking
Table 117 Quest Diagnostics Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Quest Diagnostics Incorporated: Product Benchmarking
Table 119 Quest Diagnostics Incorporated: Strategic Outlook
Table 120 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Illumina, Inc.: Product Benchmarking
Table 122 Illumina, Inc.: Strategic Outlook
Table 123 Hologic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Hologic: Product Benchmarking
Table 125 Hologic: Strategic Outlook
Table 126 Exact Sciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Exact Sciences: Product Benchmarking
Table 128 Revvity: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Revvity: Product Benchmarking
Table 130 Revvity: Strategic Outlook

List of Figures
Figure 1 In Vitro Diagnostics Market Segmentation
Figure 2 In Vitro Diagnostics Market by Product: Market Attractiveness Index
Figure 3 In Vitro Diagnostics Market by Test: Market Attractiveness Index
Figure 4 In Vitro Diagnostics Market by Application: Market Attractiveness Index
Figure 5 In Vitro Diagnostics Market by End-users: Market Attractiveness Index
Figure 6 In Vitro Diagnostics Market Attractiveness Index by Region
Figure 7 In Vitro Diagnostics Market: Market Dynamics
Figure 8 In Vitro Diagnostics Market: Impact Analysis
Figure 9 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 10 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 11 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 12 Short Term & Long Term Planning
Figure 13 Impact of U.S. and China Trade War
Figure 14 Most Impacted Countries
Figure 15 Sensitivity Mapping for Tariff Impact
Figure 16 In Vitro Diagnostics Market: Porter’s Five Forces Analysis
Figure 17 In Vitro Diagnostics Market: PEST Analysis
Figure 18 In Vitro Diagnostics Market Attractiveness Index by Product
Figure 19 In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 20 In Vitro Diagnostics Market Share Forecast by Product, 2025, 2030, 2035 (%)
Figure 21 Instruments Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 22 Instruments Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 23 Reagents & Kits Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 24 Reagents & Kits Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 25 In Vitro Diagnostics Market Attractiveness Index by Product
Figure 26 In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 27 In Vitro Diagnostics Market Share Forecast by Test, 2025, 2030, 2035 (%)
Figure 28 Clinical Chemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 29 Clinical Chemistry Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 30 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 31 Immunoassay/Immunochemistry Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 32 Molecular Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 33 Molecular Diagnostics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 34 Haematology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 35 Haematology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 36 Urinalysis Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 37 Urinalysis Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 38 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 39 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 In Vitro Diagnostics Market Attractiveness Index by Application
Figure 41 In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 42 In Vitro Diagnostics Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 43 Cardiology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 Cardiology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 45 Diabetes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 46 Diabetes Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 47 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 48 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 49 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 50 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 51 Maternal Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 52 Maternal Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 53 Mobility Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 54 Mobility Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 55 Autoimmune Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 56 Autoimmune Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 57 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 58 Drug Testing/Pharmacogenomics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 59 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 60 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 61 In Vitro Diagnostics Market Attractiveness Index by End-users
Figure 62 In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 63 In Vitro Diagnostics Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 64 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 65 Academic & Research Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 66 Diagnostic Laboratories Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 67 Diagnostic Laboratories Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 68 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 69 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 70 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 71 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 72 In Vitro Diagnostics Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
Figure 73 In Vitro Diagnostics Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 74 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Mn)
Figure 75 North America In Vitro Diagnostics Market Attractiveness Index
Figure 76 North America In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 77 North America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 78 North America In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 79 North America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 80 North America In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 81 North America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 82 North America In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 83 North America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 84 North America In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 85 North America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 86 North America In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 87 U.S. In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 88 Canada In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 89 Europe In Vitro Diagnostics Market Attractiveness Index
Figure 90 Europe In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 91 Europe In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 92 Europe In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 93 Europe In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 94 Europe In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 95 Europe In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 96 Europe In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 97 Europe In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 98 Europe In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 99 Europe In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 100 Europe In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 101 Germany In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 102 UK In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 103 France In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 104 Italy In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 105 Spain In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 106 Rest of Europe In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 107 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
Figure 108 Asia Pacific In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 109 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 110 Asia Pacific In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 111 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 112 Asia Pacific In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 113 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 114 Asia Pacific In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 115 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 116 Asia Pacific In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 117 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 118 Asia Pacific In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 119 Japan In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 120 China In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 121 India In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 122 Australia In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 123 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 124 Latin America In Vitro Diagnostics Market Attractiveness Index
Figure 125 Latin America In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 126 Latin America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 127 Latin America In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 128 Latin America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 129 Latin America In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 130 Latin America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 131 Latin America In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 132 Latin America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 133 Latin America In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 134 Latin America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 135 Latin America In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 136 Brazil In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 137 Mexico In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 138 Rest of Latin America In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 139 MEA In Vitro Diagnostics Market Attractiveness Index
Figure 140 MEA In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 141 MEA In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 142 MEA In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 143 MEA In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 144 MEA In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 145 MEA In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 146 MEA In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 147 MEA In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 148 MEA In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 149 MEA In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 150 MEA In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 151 GCC In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 152 South Africa In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 153 Rest of MEA In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 154 QIAGEN: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 155 QIAGEN: R&D, 2020-2024 (US$ Million, AGR %)
Figure 156 QIAGEN: Regional Market Shares (%), 2024
Figure 157 QIAGEN: Business Segment Market Shares (%), 2024
Figure 158 BD: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 159 BD: R&D, 2020-2024 (US$ Million, AGR %)
Figure 160 BD: Business Segment Market Shares (%), 2024
Figure 161 BIOMÉRIEUX: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 162 BIOMÉRIEUX: R&D, 2020-2024 (US$ Million, AGR %)
Figure 163 BIOMÉRIEUX: Regional Market Shares (%), 2024
Figure 164 F. Hoffmann-La Roche, Ltd.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 165 F. Hoffmann-La Roche, Ltd.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 166 F. Hoffmann-La Roche, Ltd.: Business Segment Market Shares (%), 2024
Figure 167 QuidelOrtho Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 168 QuidelOrtho Corporation: R&D, 2020-2024 (US$ Million, AGR %)
Figure 169 QuidelOrtho Corporation: Regional Market Shares (%), 2024
Figure 170 QuidelOrtho Corporation: Business Segment Market Shares (%), 2024
Figure 171 Abbott: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 172 Abbott: R&D, 2020-2024 (US$ Million, AGR %)
Figure 173 Abbott: Regional Market Shares (%), 2024
Figure 174 Abbott: Business Segment Market Shares (%), 2024
Figure 175 Agilent Technologies, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 176 Agilent Technologies, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 177 Agilent Technologies, Inc.: Regional Market Shares (%), 2024
Figure 178 Agilent Technologies, Inc.: Business Segment Market Shares (%), 2024
Figure 179 Thermofisher Scientific, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 180 Thermofisher Scientific, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 181 Thermofisher Scientific, Inc.: Regional Market Shares (%), 2024
Figure 182 Thermofisher Scientific, Inc.: Business Segment Market Shares (%), 2024
Figure 183 Siemens Healthineers AG: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 184 Siemens Healthineers AG: Regional Market Shares (%), 2024
Figure 185 Siemens Healthineers AG: Business Segment Market Shares (%), 2024
Figure 186 Bio-Rad Laboratories, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 187 Bio-Rad Laboratories, Inc.: Regional Market Shares (%), 2024
Figure 188 Bio-Rad Laboratories, Inc.: Business Segment Market Shares (%), 2024
Figure 189 Danaher: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 190 Danaher: R&D, 2020-2024 (US$ Million, AGR %)
Figure 191 Danaher: Regional Market Shares (%), 2024
Figure 192 Danaher: Business Segment Market Shares (%), 2024
Figure 193 Sysmex Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 194 Sysmex Corporation: R&D, 2020-2024 (US$ Million, AGR %)
Figure 195 Charles River Laboratories: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 196 Charles River Laboratories: Regional Market Shares (%), 2024
Figure 197 Charles River Laboratories: Business Segment Market Shares (%), 2024
Figure 198 Quest Diagnostics Incorporated: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 199 Quest Diagnostics Incorporated: Business Segment Market Shares (%), 2024
Figure 200 Illumina, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 201 Illumina, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 202 Illumina, Inc.: Regional Market Shares (%), 2024
Figure 203 Illumina, Inc.: Business Segment Market Shares (%), 2024
Figure 204 Hologic: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 205 Hologic: R&D, 2020-2024 (US$ Million, AGR %)
Figure 206 Hologic: Regional Market Shares (%), 2024
Figure 207 Hologic: Business Segment Market Shares (%), 2024
Figure 208 Exact Sciences: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 209 Exact Sciences: R&D, 2020-2024 (US$ Million, AGR %)
Figure 210 Exact Sciences: Regional Market Shares (%), 2024
Figure 211 Revvity: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 212 Revvity: R&D, 2020-2024 (US$ Million, AGR %)

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（診断薬）の最新刊レポート

Visiongain社のヘルスケアと医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（vitro diagnostics）の最新刊レポート


よくあるご質問


Visiongain社はどのような調査会社ですか?


英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2025/06/13　10:27

144.08 円

166.89 円

198.16 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都千代田区丸の内3-3-1 新東京ビル4F 430
※2025年4月26日にオフィスを移転しました。

電話：03-3582-2531
FAX：03-6551-2556
Eメール：office@dri.co.jp

会社概要 FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2025　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.